♟️ Friday 17 April 2026 Fri, 17 Apr 2026

The ASX has published its latest roster of over 40 entities suspended for more than three months, detailing looming deadlines for overdue reports and trading resumption plans. Failure to meet these could trigger removal from the official list.

Elanor Investors Group has finalised a $125 million recapitalisation with Rockworth Capital Partners, restructuring its debt and setting the stage for expansion in Asia. The move repaid existing facilities and bolstered working capital, while a Singapore acquisition awaits regulatory green light.

Electro Optic Systems (ASX: EOS) wraps up a three-year turnaround, reporting a $459 million order backlog despite a 27% revenue drop. The company expands its counter-drone and space control portfolio with the acquisition of the UK-based Interceptor business and a pending deal for MARSS, a European command-and-control software provider.

Life360 has reported its first full year of profitability alongside a 32% revenue surge to $489.5 million in 2025, driven by user growth, new Pet GPS subscriptions, and a strategic advertising platform acquisition.

AuKing Mining has agreed to acquire the Tundulu Rare Earths Project in Malawi, a large and under-explored carbonatite complex with strong historical drilling results. The acquisition is supported by a $3 million capital raise to fund exploration and drilling activities.

IRIS Metals has fortified its balance sheet with a A$5.5 million placement and is progressing towards an updated lithium-rubidium resource at Beecher while executing a farm-in deal for a tungsten project in Montana, reinforcing its diversified US critical minerals strategy.

Memphasys Limited has marked a milestone quarter with revenue surpassing A$100,000, driven by repeat orders and multi-year contracts, signalling its transition to a commercially focused biotech business.

Proteomics International Laboratories has slashed a quarter of its workforce and appointed a new CFO amid a strategic pivot to commercial diagnostics, aiming to save over $1 million annually and sharpen execution.

Axel REE is accelerating its in situ recovery (ISR) mining trials at the Caladão Project in Brazil, targeting rare earth elements and gallium extraction through a low-cost, environmentally friendly method. The company is fully funded for pilot wellfield trials at the Woolrich deposit, with expansion potential at Paraíso and Tiger Creek.

The ACCC has escalated its review of Insurance Australia Group’s proposed takeover of RAC Insurance, flagging significant competition concerns in Western Australia’s motor and home insurance markets.

The ACCC has escalated its scrutiny of Insurance Australia Group’s proposed takeover of RAC Insurance, citing potential substantial lessening of competition in Western Australia’s motor and home insurance markets.

Omnia Metals has appointed Graham Peterson as Senior Geologist to drive exploration and resource definition at its key US critical minerals projects, leveraging his extensive North American experience and cross-jurisdictional insights.

Resolution Minerals has appointed seasoned mining executive Brett Lynch as a non-executive director to bolster its U.S. growth strategy ahead of a NASDAQ listing. Lynch’s proven North American critical minerals expertise aligns with the company’s ambitions at its Horse Heaven project in Idaho.

Predictive Discovery Limited has finalized its acquisition of Robex Resources, creating a combined entity aiming for over 400,000 ounces of gold production annually by 2029. The merger consolidates two key West African gold projects under one ASX and TSX-listed company.

Zip Co reported a 41.5% jump in third quarter cash EBTDA to $65.1 million, driven by accelerated US transaction volume growth of 43.1% and steady credit losses. The company upgraded its FY26 cash EBTDA guidance to at least $260 million, highlighting robust profitability and expanding customer engagement.

New Zealand King Salmon (NZX: NZK) has sharply upgraded its FY26 earnings guidance, citing better-than-expected summer fish growth and lower mortality. The company now expects pro-forma EBITDA between $19 million and $27 million, up from $9 million to $15 million previously.